Intrinsically fluorescent cytotoxic cisplatin analogues as DNA marker molecules

Bioconjugate Chemistry

Volumn 16, Issue 2, 2005, Pages 275-282

  Criado, Julio J ^a   Fernández, Emilio R ^a   Manzano, Juan L ^a   Alonso, Angel ^a   Barrena, Susana ^a   Medarde, Manuel ^a   Pelaez, Rafael ^a   Tabernero, M Dolores ^b   Orfao, Alberto ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOTOXICITY; DNA; FLUORESCENCE; OLIGONUCLEOTIDES; SOLUTIONS;

CHEMICAL SPECIES; CIS-PLATIN; CISPLATIN; COMPLEX 1; CYTOTOXIC; DNA MARKERS; DNA-OLIGONUCLEOTIDES; ETHYLENE DIAMINE; INTRINSIC FLUORESCENCE; SYNTHESISED;

CHLORINE COMPOUNDS;

CHLORIDE; CISPLATIN DERIVATIVE; DNA; DNA MARKER; ETHYLENEDIAMINE; OLIGONUCLEOTIDE; PLATINUM DERIVATIVE;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CELL CYCLE PHASE; CHEMICAL REACTION; CHO CELL; CYTOTOXICITY; FLUORESCENCE; INCUBATION TIME; MICROSCOPY; NONHUMAN; PLASMID; QUANTUM YIELD; ROOM TEMPERATURE; STAINING; SYNTHESIS;

CRICETINAE; CRICETULUS GRISEUS;

EID: 15244344519     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc049788r     Document Type: Article

References (33)

1. Rosenberg, B. (1999) Platinum complexes for the treatment of cancer: why the search goes on (Lippert, B., Ed.) 1st ed., pp 3-30, Wiley-VCH, Zurich.
2. Wong, E., and Giandomenico, C. M. (1999) Current Status of Platinum-Based Antitumor Drugs. Chem. Rev. 99, 2451-2466.
3. Lebwohl, D., and Canetta, R. (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer 34, 1522-1534.
4. Jamieson, E. R., and Lippard, S. J. (1999) Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem. Rev. 99, 2467-2498.
5. Molenaar, C., Teuben, J.-M., Heerebrij, R. B., Tanke, H. J., and Reedijk, J. (2000) New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. J. Biol. Inorg. Chem. 5, 655-665.
6. Brooks, J. (2002) Synthesis and Characterization of Phosphorescent Cyclometalated Platinum Complexes. Inorg. Chem. 41, 3055-3066.
7. Yang, Q. Z., Wu, L. Z., Wu, Z. X., Zhang, L. P., and Tung, C. H. (2002) Long-Lived Emission from Platinum(II) Terpyridyl Acetylide Complexes. Inorg. Chem. 41, 5653-5655.
8. Konno, T. (1992) Targeting chemotherapy for hepatocarcinoma. Administration of anticancer drugs dissolved in lipiodol. Eur. J. Cancer 28, 403-409.
9. Criado, J. J., Macías, R. I. R., Medarde, M., Monte, M. J., Serrano, M. A., and Marin, J. J. G. (1997) Synthesis and characterization of the new cytostatic complex cis-diammine-platinum(II) chlorocholylglycinate. Bioconjugate Chem. 8, 453-458.
10. Criado, J. J., Domínguez, M. F., Medarde, M., Rodriguez, E., Macías, R. I. R., and Marín, J. J. G. (2000) Structural characterization, kinetic studies and in vitro biological activity of new cis-diamminebis-cholylglycinate(O,O′)Pt(II) and cis diamminebisursodeoxycholate(O,O′)Pt(II) complexes. Bioconjugate Chem. 11, 167-174.
11. Paschke, R., Kalbitz, J., and Paetz, C. (2000) Novel spacer linked bile acid-cisplatin compounds as a model for specific drug delivery, synthesis and characterization. Inorg. Chim. Acta 304, 241-249.
12. Altman, J., Castrillo, T., Beck, W., Bernhardt, G., and Schönemberg, H. (1991) Metal complexes with biologically important ligands. 62. Platinum(II) complexes of 3-(2-aminoethoxy)estrone and estradiol. Inorg. Chem. 30, 4085-4088.
13. 195Pt NMR spectra of platinum(II) peptide complexes and their growth-inhibitory activity against mouse meth a solid tumor in vivo. Bull. Chem. Soc. Jpn. 68, 2559-2565.
14. Appleton, T. G. (1997) Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules. Coord. Chem. Rev. 166, 313-359.
15. Lever, A. B. P. (1984) Inorganic Electronic Spectroscopy, 2nd ed., Elsevier, Amsterdam.
16. Lin, Y., Weissleder, R., and Tung, C.-H. (2002) Novel Near-Infrared Cyanine Fluorochromes: Synthesis, Properties, and Bioconjugation. Bioconjugate Chem. 13, 605-610.
17. Corte, M., Carney, J. T., Oppenheimer, J. D., Downey, K. E., and Cummings, S. D. (2002) Photoinduced electron transfer and energy transfer reactions of hydroxo-(2,2′:6′,2″-terpyridine) platinum(II). Inorg. Chim. Acta 333, 148-151.
18. Lakowicz, J. R. (1999) Principles of Fluorescence Spectroscopy, 2nd ed., Kluwer Academic/Plenum, New York.
19. Bauer, C., Peleg-Shulman, T. J., Gibson, D., and Wang, A. H. J. (1998) Monofunctional platinum amine complexes destabilize DNA significantly. Eur. J. Biochem 256, 253-260.
20. Sorenson, C. M., and Eastman, A. (1988) Influence of cis- diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res. 48, 6703-6707.
21. Bose, R. N. (2002) Biomolecular targets for platinum antitumor drugs. Mini Rev. Med. Chem. 2, 103-111.
22. Bancoft D. P., Lepre, C. A., and Lippard, S. J. (1990) Platinum-195 NMR kinetic and mechanistic studies of cis-and trans-diamminedichloroplatinum(II) binding to DNA J. Am. Chem. Soc. 112, 6860-6871.
23. Peleg-Shulman, T., Katzhendler, J., and Gibson, D. (2000) Effects of monofunctional platinum binding on the thermal stability and conformation of a self-complementary 22-mer. J. Inorg. Biochem. 81, 313-323.
24. Hambley, T. V. (2001) Platinum binding to DNA: structural controls and consequences. J. Chem. Soc., Dalton Trans. 2711-2718.
25. Robillard, M. S., Galanski, M., Zimmermann, W., Keppler, B. K., and Reedijk, J. (2002) Aminoethanol-dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5′-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity. J. Inorg. Biochem. 88, 254-259.
26. Costa, L. A. S., Rocha, W. R., de Almeida, W. B., and Dos Santos, H. F. (2004) The solvent effect on the aquation processes of the cis- dichloro(ethylenediamine)platinum(II) using continuum solvation models. Chem. Phys. Lett. 387, 182-187.
27. + units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding. J. Inorg. Biochem. 70, 219-226.
28. Qu, Y., Fitzgerald, J. A., Rauter, H., and Farrell, N. (2001) Approaches to Selective DNA Binding in Polyfunctional Dinuclear Platinum Chemistry. The Synthesis of a Trifunctional Compound and Its Interaction with the Mononucleotide 5′-Guanosine Monophosphate. Inorg. Chem. 40, 6324-6327.
29. 2O. J. Inorg. Biochem. 88, 268-273.
30. Bierbach, U., Sabat, M., and Farrell, N. (2000) Inversion of the Cis Geometry Requirement for Cytotoxicity in Structurally Novel Platinum(II) Complexes Containing the Bidentate N,O-Donor Pyridin-2-yl-acetate. Inorg. Chem. 39, 1882-1890.
31. Schmidt, K., Filippov, D. V., Meeuwenoord, N. J., van der Marel, G. A., van Boom, J. H., Sorenson, C. M., Barry, M. A., and Eastman, A. (1990) Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 82, 749-755.
32. El-Mehasseb, I, M., Kodaka, M., Okada, T., Tomohiro, T., Okamoto, K., and Okuno, H. (2001) Platinum (II) complex with cyclometalating 2-phenylpyridine ligand showing high cytotoxicity against cisplatin-resistant cell. J. Inorg. Biochem. 84, 157-158.
33. 3)(thiazole)]. Protein Recognition and Nucleotide Excision Repair of Mono-functional Adducts. Biochemistry 42, 792-800.